Cardurion Pharmaceuticals
Cardurion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on transforming the treatment of cardiovascular disease and heart failure. Its research and development pipeline centers on novel small-molecule programs including PDE9 inhibition for chronic heart failure (HFrEF and HFpEF) and CaMKII inhibition for cardiac diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT). Cardurion combines target discovery, adaptive clinical trial design, and precision-medicine approaches, and was surfaced as a portfolio company of GV (Google Ventures). The company publishes a corporate and R&D website but does not expose a public developer API surface at this time.
Cardurion Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Pharmaceuticals, Biotechnology, and Cardiovascular.
Cardurion Pharmaceuticals’ developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API